A carregar...
Jeremiah Metzger Lecture. Targeted cancer therapy.
I have reviewed here and elsewhere the preclinical data and the clinical trials which have demonstrated the efficacy of therapy with monoclonal antibodies that block activation of receptors for growth factors (12). Herceptin is now in clinical use. Our own antibody, C225 against the EGF receptor, sh...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Clinical and Climatological Association
2000
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2194374/ https://ncbi.nlm.nih.gov/pubmed/10881335 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|